Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving Critical Congenital Heart Disease Screening With Addition of Perfusion Measurements

NCT04056104 is registered in ClinicalTrials.gov with University of California, Davis as lead sponsor.

NCT NCT04056104
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04056104 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving Critical Congenital Heart Disease Screening With Addition of Perfusion Measurements
Lead sponsor
University of California, Davis
Phase
Not applicable
Overall status
Completed
Start date
October 23, 2019
Completion date
December 12, 2021
Enrollment
543 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

congenital heart disease